In vitro assays showed that it inhibited the proliferation of CCNE-expanded and non-expanded tumor cells, and the results of in vivo experiments suggested that III-13 had an excellent antitumor proliferation effect and good safety profile. This evidence concerns the gene CCNE1 and neoplasm.